Literature DB >> 19778261

Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: glucose as a limiting factor.

G Singh1, M A Siddiqui, V K Khanna, M P Kashyap, S Yadav, Y K Gupta, K K Pant, A B Pant.   

Abstract

Optimum time points for oxygen-glucose deprivation (OGD) and re-oxygenation have been identified to suggest the suitability of PC-12 cells as rapid and sensitive in vitro model of cerebral stroke. Further, the precise role of glucose as one of the limiting factors was ascertained. PC-12 cells were subjected to receive OGD of 1-8 h followed by re-oxygenation for 6 to 96 h in medium having glucose 0-10 mg/ml. Loss of cell viability was assessed using trypan blue dye exclusion and MTT assays. The significant (p < 0.05) reduction in percent viable cell count was started at 2 h of OGD (80.7 +/- 2.0) and continued in further OGD periods (3, 4, 5, 6, 7, and 8 h), i.e. 65.7 +/- 3.5, 59.7 +/- 4.6, 54.3 +/- 3.2, 44.7 +/- 2.9, 20.3 +/- 4.3, 5.7 +/- 2.0 of counted cells, respectively. Cells growing in glucose-free medium have shown a gradual (p < 0.001) decrease in cell viability throughout the re-oxygenation. Re-oxygenation of 24 h was found to be first statistically significant time point for all the glucose concentrations. Glucose concentration during re-oxygenation was found to be one of the key factors involved in the growth and proliferation in PC-12 cells. The OGD of 6 h followed by a re-oxygenation period of 24 h with 4-6 mg/ml glucose concentration could be recorded as optimum conditions under our experimental conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19778261     DOI: 10.1080/15376510802355216

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  9 in total

1.  trans-Resveratrol protects ischemic PC12 Cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes.

Authors:  Megha Agrawal; Vivek Kumar; Abhishek K Singh; Mahendra P Kashyap; Vinay K Khanna; Maqsood A Siddiqui; Aditya B Pant
Journal:  ACS Chem Neurosci       Date:  2012-11-09       Impact factor: 4.418

Review 2.  Stroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.

Authors:  Murali Vijayan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2016-09-06       Impact factor: 4.472

3.  Minocycline Promotes Neurite Outgrowth of PC12 Cells Exposed to Oxygen-Glucose Deprivation and Reoxygenation Through Regulation of MLCP/MLC Signaling Pathways.

Authors:  Tao Tao; Jin-Zhou Feng; Guang-Hui Xu; Jie Fu; Xiao-Gang Li; Xin-Yue Qin
Journal:  Cell Mol Neurobiol       Date:  2016-04-20       Impact factor: 5.046

4.  Apigenin mediated protection of OGD-evoked neuron-like injury in differentiated PC12 cells.

Authors:  Huizhen Guo; Songzhi Kong; Weimin Chen; Zhenhua Dai; Tongxiang Lin; Jiyan Su; Shanshan Li; Qingfeng Xie; Ziren Su; Yang Xu; Xiaoping Lai
Journal:  Neurochem Res       Date:  2014-09-11       Impact factor: 3.996

5.  Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro.

Authors:  Rui Zhang; Hong Zhang; Zhongxia Zhang; Tao Wang; Jingya Niu; Dongsheng Cui; Shunjiang Xu
Journal:  Int J Mol Sci       Date:  2012-02-15       Impact factor: 6.208

6.  Modifying PTEN recruitment promotes neuron survival, regeneration, and functional recovery after CNS injury.

Authors:  Alireza Pirsaraei Shabanzadeh; Philippe Matteo D'Onofrio; Mark Magharious; Kyung An Brian Choi; Philippe Patrick Monnier; Paulo Dieter Koeberle
Journal:  Cell Death Dis       Date:  2019-07-29       Impact factor: 8.469

7.  Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival.

Authors:  Rita Matta; Yan Feng; Lauren H Sansing; Anjelica L Gonzalez
Journal:  Stem Cell Res       Date:  2021-04-01       Impact factor: 2.020

8.  PS1 FAD mutants decrease ephrinB2-regulated angiogenic functions, ischemia-induced brain neovascularization and neuronal survival.

Authors:  YoneJung Yoon; Georgios Voloudakis; Nathan Doran; Emily Zhang; Christina Dimovasili; Lei Chen; Zhiping Shao; Spyros Darmanis; Cheuk Tang; Jun Tang; Victoria X Wang; Patrick R Hof; Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Mol Psychiatry       Date:  2020-06-15       Impact factor: 13.437

9.  660 nm red light-enhanced bone marrow mesenchymal stem cell transplantation for hypoxic-ischemic brain damage treatment.

Authors:  Xianchao Li; Wensheng Hou; Xiaoying Wu; Wei Jiang; Haiyan Chen; Nong Xiao; Ping Zhou
Journal:  Neural Regen Res       Date:  2014-02-01       Impact factor: 5.135

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.